Aneucare

AneuCare: Prenatal screening at its safest and most effective
With India being one of the highest birthing nations, there is greater incidence of Down Syndrome and with that in view, PerkinElmer introduces the AneuCareTM test – A Unique, Simple & Precise cfDNA (cell free DNA) test, designed to increase access to advanced prenatal testing to women everywhere.
Unlike other cfDNA screening methodologies, the AneuCareTM test uses a highly targeted method that provides results for three chromosomes (13, 18 and 21).
Features:
For Doctors
• Doctor Registration & Enrolment to enable sample booking by verified experts
• Extended support before, during and after sample booking
• Comprehensive inventory management module
• Order Booking & Payment Gateway integration for seamless sample booking
• Report related info available on few clicks
• Query Management through dedicated Genetic Counsellors

For Expecting Parents
• Extended support before, during and after sample booking
• Physician suggestion and connect for order booking
• Patient Stories to inspire expecting parents
• Engagement modules like Due Date Calculator & Blogs to connect expecting parents with each other
Ordering a test: Made easier than ever
For Doctors:
• Click 'Book A Test' on the home screen.
• Select ‘Physician’
• ‘Sign Up’ with all required details
• Select the test for your patient(s)
• Select the Payment option & pay
• Track your order from test booking up till result reporting in few clicks
For Expecting Parents:
• Visit Online Portal at www.aneucare.com.
• Click 'Book A Test' on the home screen.
• Select ‘Patient’ on the following page.
• ‘Sign Up’ with all required details
• Select the test in the App as prescribed by the doctor.
• Share your pregnancy-related details
• Make Payment through various options provided.
• Proceed for taking consultation & giving sample
• PerkinElmer's authorized representative will call to confirm, as per your selections.
What conditions can the AneuCareTM test identify?
The AneuCareTM test screens for Down (trisomy 21), Edwards (trisomy 18), and Patau (trisomy 13) syndromes
When can the AneuCareTM test be performed?
From 10th weeks of pregnancy
Who could benefit from the AneuCareTM test?
The AneuCareTM test is recommended for all types of pregnancies.
Some medical societies* like ACOG, ACMG, SMFM, NSGC, ISPD etc. support the use of cfDNA testing as the most sensitive screening option for traditionally screened aneuploidies.
For physicians, it is important to consider this test for pregnancies** with:
• Family history
• Parental balanced Robertsonian translocation with increased risk for trisomy 13 or 21
• Abnormal serum testing
• Abnormal ultrasound finding suggestive of aneuploidy (recommend diagnostic test)
*Brian G. Skotko et al. Genetics in Medicine 2019; Vol 21, P2285-92.
**Elizabeth T. Greeley et al. Journal of Fetal Medicine 2015; Vol 2, P11–17.

Who can recommend the AneuCareTM Test?
• Fetal Medicine Specialists
• Obstetricians & Gynaecologists
• Clinical Geneticists
How is the AneuCare test performed?
• The AneuCareTM test is performed from a simple blood sample without any risk of miscarriage
• About 10 ml blood is taken from expected mother’s arm like a normal blood test and sent to the laboratory for testing
The AneuCareTM Test workflow:
• The sample is shipped to PerkinElmer Lab via authorized collection centres
• The samples are analysed using a high precision assay which involves Rolling Circle Replication technology
• Results may be available as early as 5 working days of receiving sample
• Report will be sent to the referring Doctor as downloadable link on Doctor's mobile App and/or via email
*Pre and Post-test Genetic Counselling are available from our Genetic Counsellors
More about the AneuCareTM test:
Reach out to PerkinElmer's Authorized Channel Partners/Collection Centres/Toll Free Numbers - 1800 419 1400, 1800 12310 1400